StockData
LNAINasdaqPharmaceutical PreparationsFiscal year ends June 30

Lunai Bioworks Inc.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Oct 13, 2026
$0.47−0.21 (-30.63%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

Lunai Bioworks Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Lunai Bioworks does not break out revenue by segment, region or product in the tagged data of its filings for this period type.